BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38093163)

  • 1. Machine learning and experiments identifies SPINK1 as a candidate diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Yi S; Zhang C; Li M; Qu T; Wang J
    Discov Oncol; 2023 Dec; 14(1):231. PubMed ID: 38093163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INKA2-AS1 Is a Potential Promising Prognostic-Related Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Li W; Hong G; Lai X
    Mediators Inflamm; 2023; 2023():7057236. PubMed ID: 37181806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.
    Jia J; Ga L; Liu Y; Yang Z; Wang Y; Guo X; Ma R; Liu R; Li T; Tang Z; Wang J
    Front Immunol; 2022; 13():923031. PubMed ID: 35924241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the Diagnostic Biomarker VIPR1 in Hepatocellular Carcinoma Based on Machine Learning Algorithm.
    Ge S; Xu CR; Li YM; Zhang YL; Li N; Wang FT; Ding L; Niu J
    J Oncol; 2022; 2022():2469592. PubMed ID: 36157238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of lactate-related genes identifies POLRMT as a novel marker promoting the proliferation, migration and energy metabolism of hepatocellular carcinoma via Wnt/β-Catenin signaling.
    Wang H; Zhang Y; Du S
    Am J Cancer Res; 2024; 14(3):1316-1337. PubMed ID: 38590398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRR7-AS1 Correlates with Immune Cell Infiltration and Is a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
    Lu Y; Chen S; Wang Q; Zhang J; Pei X
    J Oncol; 2022; 2022():1939368. PubMed ID: 36059812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a Novel Diagnostic Model Based on Ferroptosis-Related Genes for Hepatocellular Carcinoma Using Machine and Deep Learning Methods.
    Yi S; Zhang C; Li M; Wang J
    J Oncol; 2023; 2023():1624580. PubMed ID: 36873737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of a Novel Immune Infiltration-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma by Machine-Learning Strategies.
    Guo X; Xiong H; Dong S; Wei X
    Gastroenterol Res Pract; 2022; 2022():5403423. PubMed ID: 35747248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High SPINK1 Expression Predicts Poor Prognosis and Promotes Cell Proliferation and Metastasis of Hepatocellular Carcinoma.
    Huang K; Xie W; Wang S; Li Q; Wei X; Chen B; Hua Y; Li S; Peng B; Shen S
    J Invest Surg; 2021 Sep; 34(9):1011-1020. PubMed ID: 32066292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAP1L1 Functions as a Novel Prognostic Biomarker Associated With Macrophages and Promotes Tumor Progression by Influencing the Wnt/β-Catenin Pathway in Hepatocellular Carcinoma.
    Shen B; Zhu W; Liu X; Jiang J
    Front Genet; 2022; 13():876253. PubMed ID: 35664324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma.
    Shek FH; Luo R; Lam BYH; Sung WK; Lam TW; Luk JM; Leung MS; Chan KT; Wang HK; Chan CM; Poon RT; Lee NP
    Cell Oncol (Dordr); 2017 Oct; 40(5):443-456. PubMed ID: 28631187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine Learning and Novel Biomarkers Associated with Immune Infiltration for the Diagnosis of Esophageal Squamous Cell Carcinoma.
    Zhang J; Zhang N; Yang X; Xin X; Jia CH; Li S; Lu Q; Jiang T; Wang T
    J Oncol; 2022; 2022():6732780. PubMed ID: 36081670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the mitophagy-related diagnostic biomarkers in hepatocellular carcinoma based on machine learning algorithm and construction of prognostic model.
    Tu DY; Cao J; Zhou J; Su BB; Wang SY; Jiang GQ; Jin SJ; Zhang C; Peng R; Bai DS
    Front Oncol; 2023; 13():1132559. PubMed ID: 36937391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of CCDC137 Expression and Its Association with Immune Infiltration in Hepatocellular Carcinoma.
    Bai L; Yang ZX; Liu JS; Wang DS; Yu HC
    Dis Markers; 2022; 2022():5638675. PubMed ID: 36061359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma.
    Xu Z; Pei C; Cheng H; Song K; Yang J; Li Y; He Y; Liang W; Liu B; Tan W; Li X; Pan X; Meng L
    Front Immunol; 2023; 14():1138524. PubMed ID: 37234166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Prognosis of Non-small Cell Lung Cancer based on Machine Learning Algorithms.
    Zhou Y; Dong Y; Sun Q; Fang C
    Comb Chem High Throughput Screen; 2023; 26(12):2170-2183. PubMed ID: 36627791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S; Zhang L; Wang H
    Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
    Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
    Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.